NetraMark Holdings Inc C.MEND

Primary Symbol: C.AIAI Alternate Symbol(s): AINMF

Healthcare Medical Devices

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

CSE:AIAI - Post by User

NetraMark Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by SkywalkerofLukeon Mar 08, 2022 5:05pm

140 Views

Post# 34497208

News

$MEND.c $MNNDF in the green today as they announced their CSO and Director Of Bioinformatics received the 'Highly Cited Paper' award from the peer-reviewed journal, Exploration of Medicine.

The research further validates $MEND ‘s AI platform and provides novel insights into Alzheimer's disease that has a diagnostics and therapeutics market valued at USD $7B.

Great to see $MEND getting recognized for their work, hopefully it starts reflecting in their sp.

https://www.newswire.ca/news-releases/nurosene-s-cso-and-director-of-bioinformatics-receives-highly-cited-paper-award-for-ai-based-alzheimer-s-research-findings-820276049.html

<< Previous

Bullboard Posts

Next >>

Mining play provides exploration update